0.2863USD+1.24%Mkt Cap: 4.26M USDP/E: —Last update: 2026-06-01
Ensysce Biosciences, Inc., a clinical-stage pharmaceutical company, develops prescription drugs for severe pain relief in opioid misuse, abuse, and overdose in the United States. It develops products using Trypsin Activa…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap4.26M USD
Enterprise Value3.30M USD
Revenue (TTM)4.71M USD
Gross Profit-5.67M USD
Net Income (TTM)-10.18M USD
Revenue/Share1.202 USD
Last Price0.2863 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees8
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-0.13
PEG—
EV/EBITDA—
EV/Revenue0.70
P/S0.88
P/B-7.59
EPS (TTM)-3.11
EPS (Forward)-2.23
52W Range
0.23002% of range2.750
52W High2.750 USD
52W Low0.2300 USD
Profitability
Gross Margin-120.42%
Oper. Margin-370.68%
EBITDA Margin0.00%
Profit Margin-250.36%
ROE-316.63%
ROA-136.54%
Growth
Revenue Growth-27.20%
Earnings Growth—
Cash Flow & Leverage
Operating CF-9.60M USD
CapEx (TTM)—
FCF Margin-116.85%
FCF Yield-129.09%
Net Debt-499.63K USD
Net Debt/EBITDA—
Balance Sheet
Debt/Equity0.10
Current Ratio0.71
Quick Ratio0.26
Book Value/Sh-0.0370 USD
Cash/Share0.0510 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:15
Split DateDec 6, 2024
Analyst Consensus
Rating0.0 (Hold)
Target (Mean)16.45 USD
Target Range16.45 USD – 16.45 USD
# Analysts1
Ownership
Shares Out.14.69M
Float14.68M
Insiders0.07%
Institutions3.31%
Short Interest
Short Ratio0.2d
Short % Float5.55%
Short % Out.5.54%
Shares Short814.61K
Short (prev mo.)64.30K
Technical
SMA 500.4401 (-34.9%)
SMA 2001.242 (-76.9%)
Beta—
S&P 52W Chg27.94%
Avg Vol (30d)3.66M
Avg Vol (10d)959.25K
Technical Indicators
RSI (14)36.8
MACD-0.0381
MACD Signal-0.0416
MACD Hist.+0.0035
BB Upper0.4203 USD
BB Middle0.3303 USD
BB Lower0.2403 USD
BB Width54.49%
ATR (14)0.0444 USD
Vol Ratio (20d)0.15x